Patriot Financial Group Insurance Agency’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.51M | Buy |
|
|||||
|
2025
Q2 | $1.13M | Buy |
|
|||||
|
2025
Q1 | $774K | Buy |
|
|||||
|
2024
Q4 | $892K | Sell |
|
|||||
|
2024
Q3 | $1.39M | Buy |
|
|||||
|
2024
Q2 | $1.48M | Buy |
|
|||||
|
2024
Q1 | $1.86M | Sell |
|
|||||
|
2023
Q4 | $1.82M | Buy |
|
|||||
|
2023
Q3 | $1.23M | Buy |
|
|||||
|
2023
Q2 | $1.49M | Buy |
|
|||||
|
2023
Q1 | $1.16M | Buy |
|
|||||
|
2022
Q4 | $547K | Buy |
|
|||||
|
2022
Q3 | $834K | Buy |
|
|||||
|
2022
Q2 | $268K | Buy |
|
|||||
|
2022
Q1 | $141K | Buy |
|
|||||
|
2021
Q4 | $94K | Buy |
|
|||||
|
2021
Q3 | $119K | Hold |
|
|||||
|
2021
Q2 | $172K | Sell |
|
|||||
|
2021
Q1 | $133K | Buy |
|
|||||
|
2020
Q4 | $132K | Sell |
|
|||||
|
2020
Q3 | $104K | Sell |
|
|||||
|
2020
Q2 | $1.21M | Sell |
|
|||||
|
2020
Q1 | $853K | Buy |
|
|||||
|
2019
Q4 | $1.17M | Sell |
|
|||||
|
2019
Q3 | $852K | Sell |
|
|||||
|
2019
Q2 | $1.16M | Buy |
|
|||||
|
2019
Q1 | $825K | Sell |
|
|||||
|
2018
Q4 | $802K | Buy |
|
|||||
|
2018
Q3 | $37K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $1.48M | Buy |
|
|||||
|
2017
Q4 | $127K | Buy |
|